Rubin Marc

Track

Insider profile

Rubin Marc's trades of Galectin Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Curis Inc (CRIS)
Transaction date
Planned sale
Price
1.05
Quantity 18,500 -39.1%
Value US$19,477
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-02-25 2019-02-22
PlS Planned sale
18,640 -4.5%
317.58
US$3,640,093 		18,640 -4.5% 317.58 US$3,640,093
2019-02-25 2019-02-21
PlS Planned sale
38,165 -33.4%
83.03
US$760,843 		38,165 -33.4% 83.03 US$760,843
2019-02-25 2019-02-21
PlS Planned sale
11,630 +27.5%
340.29
US$3,027,228 		11,630 +27.5% 340.29 US$3,027,228
2019-01-25 2019-01-23
US Curis Inc (CRIS)
PlS Planned sale
18,500 -39.1%
1.05
US$19,477 		18,500 -39.1% 1.05 US$19,477